ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

CASMED Places 1,000th FOSIGHT® Cerebral Oximeter

Print | 
Email |  Comment   Share  

44 East Industrial Road
Branford, CT, 06405

Press release date: March 20, 2014

Milestone Reflects Continued Sales Momentum for New ELITE Monitor

BRANFORD, Conn. - CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that the worldwide cumulative net shipment total of FORE-SIGHT Cerebral Oximeters reached 1,000 as of last week. This total includes monitors installed at nine of the top 20 adult cardiac surgery centers and three of the top ten pediatric centers in the U.S. The Company had previously disclosed a net cumulative total of 935 units as of December 31, 2013.

"Reaching this significant milestone is a sign of the continued strong market acceptance of the FORE-SIGHT ELITE™ monitor, which was introduced in September," said Tom Patton, CASMED's President and CEO. "Most importantly, cumulative sales of our disposable oximetry sensors have surpassed 300,000, meaning more than 150,000 adult, child, and newborn patients have benefited from the use of FORE-SIGHT technology. Improving patient care is one of CASMED's core values, and it is rewarding to know that with FORE-SIGHT oximetry we have enabled clinicians around the world to provide better outcomes for so many people.

"In response to the growing interest in cerebral oximetry and the demand for our products, we recently added four direct sales representatives in the U.S. to handle territories where we had been under-represented by independent distributors, bringing our U.S. distribution to nine direct reps plus three manufacturer's rep organizations."

About CASMED® -- Monitoring What's Vital

CASMED is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximetry technology provides highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. Direct monitoring of tissue oxygenation provides a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues, thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT Oximeters and accessories, the Company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. CASMED products are designed to provide unique monitoring solutions that are vital to patient care. For further information regarding CASMED, visit the Company's website at

Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


Post a comment about this story

(your e-mail address will not be posted)
Comment title:
To submit comment, enter the security code shown below and press 'Post Comment'.

 See related product stories
More .....
 See more product news in:
Health, Medical and Dental Supplies and Equipment
| Featured Manufacturing Jobs
 Other News from this company:
CASMED Receives China Food and Drug Administration Approval for FORE-SIGHT® Cerebral Oximeter
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Pulse Oximeters
Patient Monitoring Equipment
Join the forum discussion at:
Tools of the Trade

Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy

Error close

Please enter a valid email address